Immune checkpoint inhibition in upper tract urothelial carcinoma
Immune checkpoint inhibition in upper tract urothelial carcinoma
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Introduction
Immunotherapy is changing the way we think about and treat urothelial carcinoma (UC). The PD-1/PD-L1 pathway inhibition has shown robust efficacy, associated with an acceptable toxicity profile, in patients with locally advanced and metastatic unresectable disease, addressing a high decades-old unmet medical need.
Material and me...
Alternative Titles
Full title
Immune checkpoint inhibition in upper tract urothelial carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2456415733
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2456415733
Other Identifiers
ISSN
0724-4983
E-ISSN
1433-8726
DOI
10.1007/s00345-020-03502-7
